Journal
NATURE REVIEWS IMMUNOLOGY
Volume 10, Issue 1, Pages 36-46Publisher
NATURE PORTFOLIO
DOI: 10.1038/nri2675
Keywords
-
Categories
Funding
- US National Heart, Lung and Blood Institute [HL54591, HL75662]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL054591, R01HL075662] Funding Source: NIH RePORTER
Ask authors/readers for more resources
A key event in atherosclerosis is a maladaptive inflammatory response to subendothelial lipoproteins. A crucial aspect of this response is a failure to resolve inflammation, which normally involves the suppression of inflammatory cell influx, effective clearance of apoptotic cells and promotion of inflammatory cell egress. Defects in these processes promote the progression of atherosclerotic lesions into dangerous plaques, which can trigger atherothrombotic vascular disease, the leading cause of death in industrialized societies. In this Review I provide an overview of these concepts, with a focus on macrophage death and defective apoptotic cell clearance, and discuss new therapeutic strategies designed to boost inflammation resolution in atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available